• Explore /
  • Poster
  • / Survival outcomes of metastatic renal cell carcinoma (mRCC) with sarcomatoid differentiation (SD): A single-institutional experience and literature meta-analysis.

Survival outcomes of metastatic renal cell carcinoma (mRCC) with sarcomatoid differentiation (SD): A single-institutional experience and literature meta-analysis.

Abstract Poster

Authors

Esmail Al-Ezzi

Esmail Mutahar Al-Ezzi

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada

Esmail Mutahar Al-Ezzi , Abhenil Mittal , Brooke Wilson , Marco Iafolla , Srikala S. Sridhar , Adrian G. Sacher , Nazanin Fallah-Rad , Charles Catton , Peter W. M. Chung , Nathan Perlis , Aaron Richard Hansen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 332)

DOI

10.1200/JCO.2022.40.6_suppl.332

Abstract #

332

Poster Bd #

F5

Abstract Disclosures

Similar Posters

First Author: Shilpa Gupta

Poster

2022 ASCO Genitourinary Cancers Symposium

Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).

Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).

First Author: Matthew Scott Ernst

First Author: Esmail Mutahar Al-Ezzi

First Author: Stepan M. Esagian